Enhanced cytotoxicity against solid tumors by bispecific antibody-armed CD19 CAR T cells: a proof-of-concept study

被引:0
|
作者
Archana Thakur
John Scholler
Dana L. Schalk
Carl H. June
Lawrence G. Lum
机构
[1] University of Virginia Cancer Center,Division of Hematology/Oncology, Department of Medicine
[2] Center for Cellular Immunotherapies,undefined
[3] University of Pennsylvania,undefined
关键词
Pancreatic cancer; Breast cancer; CAR T cells; Bispecific antibody; Th; cytokines;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2007 / 2016
页数:9
相关论文
共 50 条
  • [1] Enhanced cytotoxicity against solid tumors by bispecific antibody-armed CD19 CAR T cells: a proof-of-concept study
    Thakur, Archana
    Scholler, John
    Schalk, Dana L.
    June, Carl H.
    Lum, Lawrence G.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (08) : 2007 - 2016
  • [2] Bispecific Antibody Armed Metabolically Enhanced Headless CAR T Cells
    Thakur, Archana
    Scholler, John
    Kubicka, Ewa
    Bliemeister, Edwin T.
    Schalk, Dana L.
    June, Carl H.
    Lum, Lawrence G.
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [3] Broad reactivity and enhanced potency of recombinant anti-EGFR x anti-CD3 bispecific antibody-armed activated T cells against solid tumours
    Huang, Manley T. F.
    Sharma, Vikram
    Mendelsohn, Andrew
    Wei, Qisheng
    Li, Jinjing
    Yu, Bo
    Larrick, James W.
    Lum, Lawrence G.
    ANNALS OF MEDICINE, 2022, 54 (01) : 1047 - 1057
  • [4] CAR T cells specific for CD19 can be redirected to kill CD19 negative tumors
    Ambrose, Christine
    Su, Lihe
    Wu, Lan
    Lobb, Roy R.
    Rennert, Paul D.
    CANCER RESEARCH, 2017, 77
  • [5] T and NK cells of B cell NHL patients exert cytotoxicity against lymphoma cells following binding of bispecific tetravalent antibody CD19 × CD3 or CD19 × CD16
    Lisa M. Pörtner
    Kathrin Schönberg
    Maryam Hejazi
    Daniela Brünnert
    Frank Neumann
    Lars Galonska
    Uwe Reusch
    Melvyn Little
    Rainer Haas
    Markus Uhrberg
    Cancer Immunology, Immunotherapy, 2012, 61 : 1869 - 1875
  • [6] Effect of bispecific B7H3 x CD19 CAR T cells on host CD19 expression and CAR T cell engraftment
    Pinto, Navin R.
    Albert, Catherine Michelle
    Taylor, Mallory
    Wilson, Ashley
    Rawlings-Rhea, Stephanie
    Huang, Wenjun
    Seidel, Kristy
    Narayanaswany, Prabha
    Wu, Vicky
    Mgebroff, Stephanie
    Brown, Christopher
    Vitanza, Nicholas A.
    Gardner, Rebecca Alice
    Jensen, Michael C.
    Park, Julie R.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [7] T and NK cells of B cell NHL patients exert cytotoxicity against lymphoma cells following binding of bispecific tetravalent antibody CD19 x CD3 or CD19 x CD16
    Poertner, Lisa M.
    Schoenberg, Kathrin
    Hejazi, Maryam
    Bruennert, Daniela
    Neumann, Frank
    Galonska, Lars
    Reusch, Uwe
    Little, Melvyn
    Haas, Rainer
    Uhrberg, Markus
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2012, 61 (10) : 1869 - 1875
  • [8] Akt Inhibition Enhances Memory, Proliferation and Cytotoxicity in CD19 CAR T Cells
    Mehra, Vedika
    Mitsikakou, Marina
    Pinto, Juliana Dias Alves
    Shafat, Manar S.
    Peggs, Karl S.
    Lowdell, Mark
    Pule, Martin A.
    Roddie, Claire
    MOLECULAR THERAPY, 2020, 28 (04) : 29 - 29
  • [9] Enhanced efficacy of CD19/CD22 bispecific CAR-T cells with EAAAK linker on B-cell malignancies
    Ma, Renyuxue
    You, Fengtao
    Tian, Shuaiyu
    Zhang, Tingting
    Tian, Xiaopeng
    Xiang, Shufen
    Wu, Hai
    Yang, Nan
    An, Gangli
    Yang, Lin
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 112 (01) : 64 - 74
  • [10] Priming of pancreatic cancer cells with bispecific antibody armed activated T cells sensitizes tumors for enhanced chemoresponsiveness
    Thakur, Archana
    Ung, Johnson
    Tomaszewski, Elyse N.
    Schienschang, Amy
    LaBrie, Timothy M.
    Schalk, Dana L.
    Lum, Lawrence G.
    ONCOIMMUNOLOGY, 2021, 10 (01):